FII Holdings

INDOCO REMEDIES LTD.

NSE : INDOCOBSE : 532612ISIN CODE : INE873D01024Industry : Pharmaceuticals & DrugsHouse : Private
BSE329.051.25 (+0.38 %)
PREV CLOSE ( ) 327.80
OPEN PRICE ( ) 329.95
BID PRICE (QTY) 329.30 (1)
OFFER PRICE (QTY) 330.15 (8)
VOLUME 819
TODAY'S LOW / HIGH ( )329.05 334.30
52 WK LOW / HIGH ( )307 416.95
NSE329.551.55 (+0.47 %)
PREV CLOSE( ) 328.00
OPEN PRICE ( ) 329.70
BID PRICE (QTY) 329.55 (19)
OFFER PRICE (QTY) 330.00 (416)
VOLUME 19778
TODAY'S LOW / HIGH( ) 329.30 334.10
52 WK LOW / HIGH ( )306.4 415
upfii downfii 
Current Quarter
Prev Quarter
Company Quarter Ended 202403 % of Share Quarter Ended 202312 % of Share Changeupfii

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.